Review article: Newer optical and digital chromoendoscopy techniques vs. dye-based chromoendoscopy for diagnosis and surveillance in inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 10, 2013, Pages 1198-1208

  Tontini, G E ^a   Vecchi, M ^b   Neurath, M F ^a   Neumann, H ^a,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOENDOSCOPY; COMPOUND BAND IMAGING; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING EQUIPMENT; DIAGNOSTIC TEST; DIGITAL IMAGING; DISEASE SURVEILLANCE; DYE BASED CHROMOENDOSCOPY; DYE LESS CHROMOENDOSCOPY; DYSPLASIA; ENDOSCOPE; ENTERITIS; FALSE POSITIVE RESULT; FLUORESCENCE IMAGING; HUMAN; INTERMETHOD COMPARISON; NARROW BAND IMAGING; OPTICAL INSTRUMENTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURFACE ENHANCEMENT; TONE ENHANCEMENT; WHITE LIGHT ENDOSCOPY;

COLONOSCOPY; COLORING AGENTS; ENDOSCOPY; ENDOSCOPY, GASTROINTESTINAL; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84885960393     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12508     Document Type: Review

References (83)

1. Collins PD, Mpofu C, Watson AJ, Rhodes JM,. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006; 2: CD000279.
2. Eaden JA, Abrams KR, Mayberry JF,. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-35.
3. Lashner BA,. Colon cancer surveillance in ulcerative colitis. Semin Gastrointest Dis 1991; 2: 126-31.
4. Itzkowitz SH, Harpaz N,. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004; 126: 1634-48.
5. Tytgat GN, Dhir V, Gopinath N,. Endoscopic appearance of dysplasia and cancer in inflammatory bowel disease. Eur J Cancer 1995; 31: 1174-7.
6. Bernstein CN, Shanahan F, Weinstein WM,. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994; 343: 71-4.
7. Sugita A, Sachar DB, Bodian C, et al,. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut 1991; 32: 167-9.
8. Goldmann H,. Significance and detection of dysplasia in chronic colitis. Cancer 1996; 78: 2261-3.
9. Van Assche G, Dignass A, Bokemeyer B, et al,. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013; 7: 1-33.
10. Farraye FA, Odze RD, Eaden J, Itzkowitz SH,. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010; 138: 746-74.
11. Cairns SR, Scholefield JH, Steele RJ, et al,. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups. Gut 2010; 59: 666-89.
12. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM,. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 2009; 104: 739-50.
13. Rutter MD, Saunders BP, Wilkinson KH, et al,. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006; 130: 1030-8.
14. Leung K, Pinsky P, Laiyemo AO, Lanza E, Schatzkin A, Schoen RE,. Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study. Gastrointest Endosc 2010; 71: 111-7.
15. Kiesslich R, Goetz M, Lammersdorf K, et al,. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 2007; 132: 874-82.
16. Robertson DJ, Greenberg ER, Baron JA, et al,. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005; 129: 34-41.
17. Rutter M, Bernstein C, Matsumoto T, Kiesslich R, Neurath MF,. Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining. Endoscopy 2004; 36: 1109-14.
18. Rubin CE, Haggitt RC, Burmer GC, et al,. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992; 103: 1611-20.
19. Ransohoff DF, Riddell RH, Levin B,. Ulcerative colitis and colonic cancer problems in assessing diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum 1985; 28: 383-8.
20. Obrador A, Ginard D, Barranco L,. Review article: colorectal cancer surveillance in ulcerative colitis-what should we be doing? Aliment Pharmacol Ther 2006; 24: 56-63.
21. van Rijn AF, Fockens P, Siersema PD, Oldenburg B,. Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands. World J Gastroenterol 2009; 15: 226-30.
22. Rodriguez SA, Eisen GM,. Surveillance and management of dysplasia in ulcerative colitis by U.S. gastroenterologists: in truth, a good performance. Gastrointest Endosc 2007; 66: 1070.
23. Vienne A, Simon T, Cosnes J, et al,. Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort. Aliment Pharmacol Ther 2011; 34: 188-95.
24. Eaden JA, Ward BA, Mayberry JF,. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 2000; 51: 123-8.
25. Ullman TA, Croog V, Harpaz N, Itzkowitz S,. Biopsy specimen numbers in the routine practice of surveillance colonoscopy in ulcerative colitis (UC). Gastroenterology 2004; 126: 471.
26. Kiesslich R, Neurath MF,. Chromoendoscopy in inflammatory bowel disease. Gastroenterol Clin North Am 2012; 41: 291-302.
27. Marion JF, Waye JD, Present DH, et al,. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008; 103: 2342-9.
28. Subramanian V, Mannath J, Ragunath K, Hawkey CJ,. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011; 33: 304-12.
29. Ullman TA,. Chromoendoscopy should be the standard method and more widely used for cancer surveillance colonoscopy in ulcerative colitis. Inflamm Bowel Dis 2007; 13: 1273-4.
30. Hurlstone DP, Sanders DS, Lobo AJ, McAlindon ME, Cross SS,. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy 2005; 37: 1186-92.
31. Kiesslich R, Neurath MF,. Chromoendoscopy: an evolving standard in surveillance for ulcerative colitis. Inflamm Bowel Dis 2004; 10: 695-6.
32. Hurlstone DP, McAlindon ME, Sanders DS, Koegh R, Lobo AJ, Cross SS,. Further validation of high-magnification chromoscopic colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2004; 126: 376-8.
33. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC,. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004; 53: 256-60.
34. Kiesslich R, Fritsch J, Holtmann M, et al,. Methylene blue aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003; 124: 880-8.
35. East JE, Kamm MA, Bassett P, Saunders BP,. Magnification pan-chromoendoscopy remains the mainstay for colitis dysplasia detection and differentiation. Gastroenterology 2007; 133: 366-7.
36. Wu L, Li P, Wu J, Cao Y, Gao F,. The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta-analysis of six randomized controlled trials. Colorectal Dis 2012; 14: 416-20.
37. ASGE Technology Committee. Chromoendoscopy. Gastrointest Endosc 2007; 66: 639-49.
38. Olliver JR, Wild CP, Sahay P, et al,. Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus. Lancet 2003; 362: 373.
39. Neumann H, Neurath MF, Mudter J,. New endoscopic approaches in IBD. World J Gastroenterol 2011; 17: 63-8.
40. Kuznetsov K, Lambert R, Rey JF,. Narrow-band imaging: potential and limitations. Endoscopy 2006; 38: 76-81.
41. Muto M, Horimatsu T, Ezoe Y, Morita S, Miyamoto S,. Improving visualization techniques by narrow band imaging and magnification endoscopy. J Gastroenterol Hepatol 2009; 24: 1333-46.
42. Gheorghe C,. Narrow-band imaging endoscopy for diagnosis of malignant and premalignant gastrointestinal lesions. J Gastrointestin Liver Dis 2006; 15: 77-82.
43. Gono K, Obi T, Yamaguchi M, et al,. Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt 2004; 9: 568-77.
44. Gono K, Yamazaki K, Doguchi N, et al,. Endoscopic observation of tissue by narrow band illumination. Opt Rev 2003; 10: 1-5.
45. Bessissow T, Bisschops R,. Advanced endoscopic imaging for dysplasia surveillance in ulcerative colitis. Expert Rev Gastroenterol Hepatol 2013; 7: 57-67.
46. Morson BC, Pang LSC,. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967; 8: 423-34.
47. Leidenius M, Kellokumpun I, Husa A, et al,. Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Gut 1991; 32: 1521-5.
48. Ullman TA, Loftus VE Jr, Kakar S, et al,. The fate of low-grade dysplasia in ulcerative colitis. Am J Gastroenterol 2002; 97: 922-7.
49. Thomas T, Abrams KA, Robinson RJ, Mayberry JF,. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 2007; 25: 657-68.
50. Ullman T, Odze R, Farraye FA,. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflamm Bowel Dis 2009; 15: 630-8.
51. Neumann H, Vieth M, Langner C, Neurath MF, Mudter J,. Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J Gastroenterol 2011; 17: 3184-91.
52. Matsumoto T, Kudo T, Jo Y, Esaki M, Yao T, Iida M,. Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study. Gastrointest Endosc 2007; 66: 957-65.
53. Nishio Y, Ando T, Maeda O, et al,. Pit patterns of rectal mucosa assessed by magnifying colonoscopy are predictive of relapse in patients with quiescent ulcerative colitis. Gut 2006; 55: 1768-73.
54. Kunihiro M, Tanaka S, Sumii M, et al,. Magnifying colonoscopic features of ulcerative colitis reflect histologic inflammation. Inflamm Bowel Dis 2004; 10: 737-44.
55. Fujiya M, Saitoh Y, Nomura M, et al,. Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis. Gastrointest Endosc 2002; 56: 535-42.
56. Matsumoto T, Kuroki F, Mizuno M, et al,. Application of magnifying chromoscopy for the assessment of severity in patients with mild to moderate ulcerative colitis. Gastrointest Endosc 1997; 46: 400-5.
57. Dekker E, van den Broek FJ, Reitsma JB, et al,. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007; 39: 216-21.
58. van den Broek FJ, Fockens P, van Eeden S, et al,. Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy 2011; 43: 108-15.
59. Ignjatovic A, East JE, Subramanian V, et al,. Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol 2012; 107: 885-90.
60. Kiesslich R, Hoffman A, Neurath MF,. Colonoscopy, tumors, and inflammatory bowel disease-new diagnostic methods. Endoscopy 2006; 38: 5-10.
61. Pellisé M, Lõpez-Cerõn M, Rodríguez de Miguel C, et al,. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. Gastrointest Endosc 2011; 74: 840-8.
62. Bisschops R, Bessissow T, Baert F, et al,. Chromo-endoscopy versus narrow band imaging in ulcerative colitis: a prospective randomized controlled trial. Endoscopy 2012; 44: 26.
63. van den Broek FJ, Fockens P, van Eeden S, et al,. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut 2008; 57: 1083-9.
64. Neurath MF, Travis SP,. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 2012; 61: 1619-35.
65. Cromer WE, Mathis JM, Granger DN, Chaitanya GV, Alexander JS,. Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol 2011; 17: 578-93.
66. Deban L, Correale C, Vetrano S, Malesci A, Danese S,. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol 2008; 172: 1457-66.
67. Koutroubakis IE, Tsiolakidou G, Karmiris K, Kouroumalis EA,. Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 515-23.
68. Jiang HQ, Thurnheer MC, Zuercher AW, Boiko NV, Bos NA, Cebra JJ,. Interactions of commensal gut microbes with subsets of B- and T-cells in the murine host. Vaccine 2004; 22: 805-11.
69. Oshima T, Laroux FS, Coe LL, et al,. Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. Microvasc Res 2001; 61: 130-43.
70. Dharmani P, Chadee K,. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Curr Mol Pharmacol 2008; 1: 195-212.
71. Yacyshyn BR,. Adhesion molecule therapeutics in IBD. Inflamm Bowel Dis 2008; 2: 279-80.
72. Danese S, Dejana E, Fiocchi C,. Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J Immunol 2007; 178: 6017-22.
73. Spalinger J, Patriquin H, Miron MC, et al,. Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology 2000; 217: 787-91.
74. Maconi G, Sampietro GM, Russo A, et al,. The vascularity of internal fistulae in Crohn's disease: an in vivo power Doppler ultrasonography assessment. Gut 2002; 50: 496-500.
75. Danese S, Fiorino G, Angelucci E, et al,. Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study. World J Gastroenterol 2010; 16: 2396-400.
76. Kudo T, Matsumoto T, Esaki M, Yao T, Iida M,. Mucosal vascular pattern in ulcerative colitis: observations using narrow band imaging colonoscopy with special reference to histologic inflammation. Int J Colorectal Dis 2009; 24: 495-501.
77. Matsumoto T, Kudo T, Yao T, et al,. Magnifying NBI colonoscopic findings in ulcerative colitis. Stomach Intestine 2007; 42: 877-81.
78. Matsumoto T, Kudo T, Yao T, lida M,. Autofluorescence imaging colonoscopy in ulcerative colitis: comparison with conventional and narrow-band imaging colonoscopy. Dig Endosc 2007; 19: 139-44.
79. Esaki M, Kubokura N, Kudo T, Matsumoto T,. Endoscopic findings under narrow band imaging colonoscopy in ulcerative colitis. Dig Endosc 2011; 1: 140-2.
80. Neumann H, Vieth M, Grauer M, et al,. Virtual chromoendoscopy with i-scan for diagnosis of mucosal healing in patients with inflammatory bowel disease: a randomized double-blind controlled study. Inflamm Bowel Dis 2013; 19: 1935-42.
81. Neumann H, Fry LC, Bellutti M, Malfertheiner P, Mönkemüller K,. Double-balloon enteroscopy-assisted virtual chromoendoscopy for small-bowel disorders: a case series. Endoscopy 2009; 41: 468-71.
82. Odze RD,. What are the guidelines for treating adenoma-like DALMs in UC? Inflamm Bowel Dis 2008; 14: 243-4.
83. Vieth M, Behrens H, Stolte M,. Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment. Gut 2006; 55: 1151-5.